Lampang Hospital is the main hospital of Lampang Province, Thailand and is classified under the Ministry of Public Health as a regional hospital. It is the tertiary-care transfer hospital for patients in Phrae and Nan Provinces.

There are 743 beds in Lampang Hospital.

During the past decade, Lampang Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lampang Hospital" #1 sponsor was "Institut de Recherche pour le Developpement" with 7 trials, followed by "Rajavithi Hospital" with 3 trials sponsored, "Arcus Biosciences, Inc." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Bolton Medical" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lampang Hospital" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 4 trials as a collaborator, "Harvard School of Public Health (HSPH)" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Ministry of Health, Thailand" with 2 trials as a collaborator and "Centers for Disease Control and Prevention" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Lampang Hospital" are "HIV Infections" (4 trials), "Pregnancy" (3 trials), "Cervical Dystonia" (2 trials), "Abdominal Aortic Aneurysm" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "Lampang Hospital" in a lesser frequency.

Most popular intervention types in "Lampang Hospital" are "Drug" (10 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASA 100 mg" (1 trials), "Anti-HBV antiviral prophylaxis" (1 trials), "Antiretroviral Drug Combination Switching Criteria" (1 trials), "Carboplatin" (1 trials) and "Domvanalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lampang Hospital" are 10 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Lampang Hospital". 1 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Lampang Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lampang Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".